Article
Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients.
Human mutation - 1 Jun 2003
Kim Lyoung Hyo, Shin Hyoung Doo, Park Byung Lae, Jung Ji Hyun, Kim Jun Yeun, Kim Yoon Jun, Lee Hyo-Suk
Abstract excerpt
Human nuclear factor of kappa light chain gene enhancer in B cells inhibitor, alpha (NFKBIA) inhibits the action of NF-kappaB by forming a heterodimer with NF-kappaB, and preventing its translocation to the nucleus. We have sequenced a human NFKBIA full gene including -1000bp promoter region to identify its gene polymorphisms as a potential candidate gene for host genetic study of Hepatocellular Carcinoma (HCC)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
